APA (7th ed.) Citation

MH, K., Q, S., SA, A., JM, H., W, M. R., E, C., . . . AP, V. (2016). Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA surgery, 151(8), e161137. https://doi.org/10.1001/jamasurg.2016.1137

Chicago Style (17th ed.) Citation

MH, Katz, et al. "Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101." JAMA Surgery 151, no. 8 (2016): e161137. https://doi.org/10.1001/jamasurg.2016.1137.

MLA (9th ed.) Citation

MH, Katz, et al. "Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101." JAMA Surgery, vol. 151, no. 8, 2016, p. e161137, https://doi.org/10.1001/jamasurg.2016.1137.